Bruker Corporation – Quartalsabschluss (NASDAQ:BRKRP)

Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik Dividenden

Vierteljährlich Jährlich

Market Capitalization 9.13 B
Employee 11 K
Founded N/A
CEO Frank Laukien
Website www.bruker.com
Headquarter Delaware, United States
FIGI BBG000CL1FG7
Industry Medizinische Geräte

Gesamtumsatz

Jahresüberschuss

Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)

Gesamtverschuldung

Freier Cashflow

Zahlungsmittel und Zahlungsmitteläquivalente

Kurs-Gewinn-Verhältnis

-1 176.04

Preis-Umsatz-Verhältnis

12.4

Dividende je Aktie

—

Dividendenrendite in %

—

Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A

Bruker Corporation is an American manufacturer of scientific instruments for molecular and materials research, as well as for industrial and applied analysis. It is headquartered in Billerica, Massachusetts, and is the publicly traded parent company of Bruker Scientific Instruments and Bruker Energy & Supercon Technologies divisions. In April 2010, Bruker created a Chemical Analysis Division under the Bruker Daltonics subsidiary. This division contains three former Varian product lines: ICPMS systems, laboratory gas chromatography, and GC-triple quadrupole mass spectrometer. In 2012, it sponsored the Fritz Feigl Prize, and since 1999 the company has also sponsored the Günther Laukien Prize.